An updated review on asbestos and related diseases in China

Courtice, Midori N.; Lin, Sihao; Wang, Xiaorong

doi:10.1179/1077352512z.00000000021

Cited by 40 publications

(29 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It should also be observed that the permitted occupational exposure limit (OEL) to asbestos was progressively lowered in the last years [5] (p. 249) and [46].…”

Section: Laws On the Prevention Control And Compensation Of Asbestomentioning

confidence: 99%

“…clearly attributable to chrysotile exposure in Chinese studies than in mostly of the western studies with a prevalence of male smoker cohorts [5] (p. 250) and [30].…”

mentioning

confidence: 99%

“…It should nevertheless be observed that the officially reported incidence of asbestos related diseases, especially mesothelioma, does not properly reflect its large use and the actual relatively high exposures to asbestos; the reason probably resides in the fact that Chinese workers employed in dangerous and laborious occupations have a lower life expectancy, and can therefore die before the mesothelioma, characterized by a very long latency, develops and in the fact that, due to a poor diagnosis quality, mesothelioma cases can be misdiagnosed for lung cancers [5] (p. 251).…”

mentioning

confidence: 99%

See 2 more Smart Citations

The Rough Path to the Compensation of Asbestos Damages in China

Coggiola

2017

Sustainability

View full text Add to dashboard Cite

Abstract:The article investigates the issue of asbestos damages compensation in China. Today, China is a major player in the global market of asbestos production and consumption. Therefore, a large number of Chinese workers are employed in the asbestos industries and an even larger number of individuals are exposed to asbestos for non-occupational reasons. Although there is no official data on the numbers of asbestos-related diseases in China, it is estimated that a significant part of the population developed asbestos-related diseases and that there will be an augmentation of those diseases in the future. This article examines the Chinese legal provisions on the prevention, control, and compensation of asbestos related diseases; both in cases of environmental and occupational exposures, and analyzes if and when those provisions are applied. This research shows that although the laws and the regulations enacted by the Chinese government provide protection for those exposed to asbestos dust, and entitle them to some compensation or indemnity where those exposures caused damages, the implementation of those rules is actually very difficult, due to a variety of different reasons. Those reasons can vary from problems in the interpretation and implementation of the laws and regulations, to difficulties in the access to justice and in the adjudication by the courts, regarding occupational and environmental damages. In most of these cases, the consequences of these problems are a poor and inefficient protection of the victims of the asbestos exposures for the damages suffered.

show abstract

“…It should also be observed that the permitted occupational exposure limit (OEL) to asbestos was progressively lowered in the last years [5] (p. 249) and [46].…”

Section: Laws On the Prevention Control And Compensation Of Asbestomentioning

confidence: 99%

“…clearly attributable to chrysotile exposure in Chinese studies than in mostly of the western studies with a prevalence of male smoker cohorts [5] (p. 250) and [30].…”

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

The Rough Path to the Compensation of Asbestos Damages in China

Coggiola

2017

Sustainability

View full text Add to dashboard Cite

show abstract

“…Accordingly, the global epidemiological situation of pneumoconiosis must be understood in order to develop an effective control strategy. Although many epidemiological studies of pneumoconiosis (e.g., Seaton et al, 1991;Linch et al, 1998;Kauppinen et al, 2000;Rosenman et al, 2003;Saiyed and Tiwari, 2004;Soutar et al, 2004;Carneiro et al, 2006;Smith and Leggat, 2006;Bang et al, 2008;Madl et al, 2008;Mazurek and Attfield, 2008;Choi et al, 2010;Laney et al, 2010;Nelson et al, 2010;Suarthana et al, 2011;Nelson, 2013), more than 20 articles about the epidemiological analysis of pneumoconiosis in domestic provinces and cities (e.g., Li et al, 2010;Courtice et al, 2012;Zhang et al, 2013;Mo et al, 2014), and 1 article from Changji, Xinjiang have been published in the last 5 years, there have been no reports about the epidemiological analysis of pneumoconiosis in the Xinjiang Uygur Autonomous Region or by the Urumqi Railway Bureau. Accordingly, to understand the epidemiological characteristics and dynamic changes of new cases of pneumoconiosis in Xinjiang in recent years, this epidemiological study investigated pneumoconiosis cases before June 2006 and from July 2006 through 2010 in the Xinjiang Uygur Autonomous Region as well as cases reported by the Urumqi Railway Bureau from 1981 to 2012.…”

Section: Introductionmentioning

confidence: 99%

Epidemiological analysis of pneumoconiosis in the Xinjiang Uygur Autonomous Region and cases reported by the Urumqi Railway Bureau

Liu¹,

Li²,

Wei³

et al. 2015

Genet. Mol. Res.

View full text Add to dashboard Cite

“…In China, the estimated number of workers exposed to asbestos was one million [2], and the excess mortality for these population might be substantial [3]. In face of the substantial burden of non-malignant and malignant asbestos-related diseases (ARDs), new molecular biomarkers for screening the subjects with high risk of developing ARDs are undoubtedly needed.…”

Section: Introductionmentioning

confidence: 99%

Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population

Zhang

Jiang

et al. 2015

Environ Health Prev Med

View full text Add to dashboard Cite

Objectives This study investigated the mesothelin (MSLN) methylation and its relationship with soluble mesothelin-related protein (SMRP) levels in participants stratified by asbestos exposure scenarios and benign asbestos-related diseases (ARDs). Methods The presence of benign ARDs was confirmed through chest X-ray and the asbestos exposure history was obtained using a standardized questionnaire in this study, including 262 participants. Sera SMRP were measured using MESOMARK, and MSLN methylation in genomic DNA extracted from whole blood was detected by real-time methylation-specific PCR. Covariates were compared with SMRP concentrations using correlation analysis and the potential covariates affecting SMRP were determined by multiple linear regression analysis, and the distribution of methylation status was analyzed by Chi-square test. Results There was a trend toward elevation of SMRP values in healthy individuals exposed to asbestos as compared with those without asbestos exposure. The highest median level of SMRP was 1.3 nM in subjects with asbestosis, followed by cases with pleura plaque and asbestosis (1.2 nM), pleura plaque (0.9 nM), healthy subjects with occupational exposure (0.9 nM), non-occupational exposure (0.8 nM), and mixed exposure (0.8 nM). Within asbestosis cases, those with higher profusion scores had higher SMRP values than those with lower profusion scores (1.6 vs. 0.8 nM). Based on multi-regression analysis, the trend toward elevation of SMRP remained significant in subjects with occupational exposure or in those with asbestosis, as compared with healthy subjects without exposure (p \ 0.01), although body mass index had an effect on SMRP (p \ 0.0001). Regardless of the differences in SMRP levels among these subgroups, MSLN methylation ranged from 80.5 to 92.5 %, with no significant difference. The elevated level of SMRP in asbestosis with higher profusion scores could not be attributed to low MSLN methylation status. Conclusions Our findings suggest that the elevation of SMRP is related to asbestos exposure and benign ARDs especially for cases with high profusion scores, which is independent of MSLN methylation.

show abstract

An updated review on asbestos and related diseases in China

Abstract: Government policies to prevent ARD have been implemented but more actions are necessary to ensure compliance and ultimately, the complete elimination of asbestos to prevent a heavy future disease burden.

Cited by 40 publications

References 21 publications

The Rough Path to the Compensation of Asbestos Damages in China

The Rough Path to the Compensation of Asbestos Damages in China

Epidemiological analysis of pneumoconiosis in the Xinjiang Uygur Autonomous Region and cases reported by the Urumqi Railway Bureau

Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population

Contact Info

Product

Resources

About